Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of a dual Ras and ARF6 inhibitor from a GPCR endocytosis screen
Jenna Giubilaro, Doris A. Schuetz, Tomasz Maciej Stępniewski, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Nucleolin in the cell membrane promotes Ang II-mediated VSMC phenotypic switching by regulating the AT1R internalization function
Fang Li, Zhijie Shen, Yinzhuang Zhang, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
A slow but steady nanoLuc: R162A mutation results in a decreased, but stable, nanoLuc activity
Wesam S. Ahmed, Anupriya M. Geethakumari, Asfia Sultana, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131864-131864
Open Access | Times Cited: 5
Aldosterone breakthrough from a pharmacological perspective
Masaki Mogi
Hypertension Research (2022) Vol. 45, Iss. 6, pp. 967-975
Closed Access | Times Cited: 17
Structural insights, regulation, and recent advances of RAS inhibitors in the MAPK signaling cascade: a medicinal chemistry perspective
Vimal H. Prajapati, Ankit Kumar Singh, Adarsh Kumar, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Arf6 as a therapeutic target: Structure, mechanism, and inhibitors
Dejuan Sun, Yuanyuan Guo, Piyu Tang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4089-4104
Open Access | Times Cited: 8
m6A demethylase ALKBH5 attenuates doxorubicin-induced cardiotoxicity via posttranscriptional stabilization of Rasal3
Rifeng Gao, Kun Yang, Yanan Qu, et al.
iScience (2023) Vol. 26, Iss. 3, pp. 106215-106215
Open Access | Times Cited: 7
Membrane trafficking alterations in breast cancer progression
Andreia Ferreira, Pedro Castanheira, Cristina Escrevente, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
In silico approaches for drug repurposing in oncology: a scoping review
Bruno Raphael Ribeiro Cavalcante, Raíza Dias Freitas, Leonardo de Oliveira Siquara da Rocha, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
The Application of High‐Throughput Approaches in Identifying Novel Therapeutic Targets and Agents to Treat Diabetes
Siyi He, Gareth E. Lim
Advanced Biology (2022) Vol. 7, Iss. 2
Closed Access | Times Cited: 5
Daily Brief Heat Therapy Reduces Seizures in A350V IQSEC2 Mice and Is Associated with Correction of AMPA Receptor-Mediated Synaptic Dysfunction
Reem Jada, Veronika Borisov, Eliezer Laury, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3924-3924
Open Access | Times Cited: 2
Growth Factor Receptor Implications in Breast Cancer: Prospects for Their Molecular Transactivation in the Future and Obstacles for Target Therapy
Esteban Acosta-Ramos, Mariana Segovia‐Mendoza, J. Alberto Olivares‐Reyes
(2024), pp. 237-301
Closed Access
A Slow but Steady NanoLuc: R162A mutation results in a decreased, but stable, NanoLuc activity
Wesam S. Ahmed, Anupriya M. Geethakumari, Asfia Sultana, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top